| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6a1be3f4ff2311c3db591fc7aad19d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1e5d6003036d57e4f7fe9e6134be4b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35f72625d68dc75d3f3f9a04e91dc4d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc140323099d9558cae582fdc1a17dfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ce1cf7cb5e59af1cbfe97ec9d22be8b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate |
2005-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97fd40fad72dd2422c01a7f09107e51a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bcb5c7bb7171b2f1183939f3812a2ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4142f58cd150000dc822b6e57d03557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cbaab1a7bbf27ea24673a518f8126c2 |
| publicationDate |
2006-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006039692-A3 |
| titleOfInvention |
Modified release ibuprofen dosage form |
| abstract |
The present invention is a solid dosage form for oral administration of ibuprofen comprising a modified release formulation of ibuprofen which provides an immediate burst effect and thereafter a sustained release of sufficient ibuprofen to maintain blood levels at least 6.4 µg/ml over an extended period of at least 8 hours following administration of a single dose. The dosage form releases ibuprofen at a rate sufficient to initially deliver a effective amount of ibuprofen within about 2.0 hours following administration. The dosage form then subsequently delivers the remaining amount of ibuprofen at a relatively constant rate sufficient to maintain a level of ibuprofen over a predetermined delivery period of for at least 8 hours. |
| priorityDate |
2004-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |